ID   A2/82
AC   CVCL_E2Y7
DR   Cosmic; 713866
DR   Cosmic; 929147
RX   PubMed=8263009;
RX   PubMed=9673367;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9673367).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=8263009).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=8263009; DOI=10.1007/BF01202192;
RA   Kashii T., Mizushima Y., Monno S., Nakagawa K., Kobayashi M.;
RT   "Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility
RT   genes in human lung cancer cell lines by the polymerase chain
RT   reaction/single-strand conformation polymorphism method.";
RL   J. Cancer Res. Clin. Oncol. 120:143-148(1994).
//
RX   PubMed=9673367;
RA   Fujishita T., Mizushima Y., Kashii T., Kobayashi M.;
RT   "Coincidental alterations of p16INK4A/CDKN2 and other genes in human
RT   lung cancer cell lines.";
RL   Anticancer Res. 18:1537-1542(1998).
//